Tomography News and Research

RSS

Pediatric NEXUS Head CT DI guides selective imaging decisions in blunt trauma patients

The Pediatric NEXUS Head Computed Tomography Decision Instrument reliably identifies blunt trauma patients who require head CT imaging and could significantly reduce the use of CT imaging.

18 Jul 2018

Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery

Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.

18 Jul 2018

CT scans may raise brain tumor risk

A new study in the Journal of the National Cancer Institute suggests that CT scans, commonly used in medical imaging, may increase the risk of brain tumors.

18 Jul 2018

UW-Madison researchers develop new method to track Parkinson's damage in the heart

A new way to examine stress and inflammation in the heart will help Parkinson's researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.

13 Jul 2018

Imaging techniques may help assess immune system recovery in HIV patients

Findings from an animal study suggest that a non-invasive imaging technique could, with further development, become a useful tool to assess immune system recovery in people receiving treatment for HIV infection.

13 Jul 2018

Four-protein biomarker blood test improves lung cancer risk assessment for smokers

A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international research team reports in JAMA Oncology.

12 Jul 2018

New biosensor could enable early non-invasive diagnosis of Alzheimer's disease through magnetic resonance imaging

UPM researchers are involved in the development of a new biosensor that can be useful to achieve an early non-invasive diagnosis of Alzheimer's disease using magnetic resonance imaging.

12 Jul 2018

Study finds disrupted stress response in people with schizophrenia

Stressful situations affect the brain and body differently in people with schizophrenia compared to people without the mental illness or individuals at high risk for developing psychosis, a new CAMH study shows.

11 Jul 2018

Researchers develop personalized 'Therapeutic Intervention Fingerprint'

Personalized medicine - delivering therapies specially tailored to a patient's unique physiology - has been a goal of researchers and doctors for a long time.

11 Jul 2018

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

A new positron emission tomography imaging method more fully evaluates the extent of rheumatoid arthritis by targeting translocator protein expression in the synovium (joint lining tissue).

10 Jul 2018

Researchers use information from computer tomography images to simulate heart function

Researchers at Linköping University have for the first time been able to use information from computer tomography images to simulate the heart function of an individual patient.

9 Jul 2018

LLNL employs high-performance computing for better understanding of TBI

Since the wars in Afghanistan and Iraq began in 2001, more than 350,000 cases of traumatic brain injury in servicemen and women have been reported to the Department of Defense.

3 Jul 2018

Finnish researchers gain new insights on brain activity during general anesthesia

Finnish researchers have gained new information on brain activity during general anesthesia by recording changes in the electrical activity of the brain.

3 Jul 2018

Johns Hopkins researchers reveal potential of AI in medical imaging and diagnostics

The advent of electronic medical records with large image databases, along with advances in artificial intelligence with deep learning, is offering medical professionals new opportunities to dramatically improve image analysis and disease diagnostics.

29 Jun 2018

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors.

26 Jun 2018

Novel theranostic agent designed for precise tumor diagnosis and therapy

A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging.

26 Jun 2018

MILabs announces innovative PET imaging features in its new VECTor6 system

The new VECTor6 imaging system is packed with exclusive preclinical PET imaging features including 0.6 mm 18F resolution, the elimination of positron-range blurring for e.g. 124I, simultaneous multi-isotope PET and PET/SPECT tomography, and α- and β-radiotherapy imaging.

26 Jun 2018

New molecular imaging method could help effectively tackle brain conditions

A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.

26 Jun 2018

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.

25 Jun 2018

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Advanced Accelerator Applications S.A., a Novartis company and leader in nuclear medicine theragnostics, today announced that the first patients have been dosed in two Phase I/II clinical studies of radiolabeled PSMA-R2, a urea-based ligand of Prostate-Specific Membrane Antigen, which is commonly expressed on prostate cancer cells.

22 Jun 2018

Tomography News and Research

Pediatric NEXUS Head CT DI guides selective imaging decisions in blunt trauma patients

Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery

CT scans may raise brain tumor risk

UW-Madison researchers develop new method to track Parkinson's damage in the heart

Imaging techniques may help assess immune system recovery in HIV patients

Four-protein biomarker blood test improves lung cancer risk assessment for smokers

New biosensor could enable early non-invasive diagnosis of Alzheimer's disease through magnetic resonance imaging

Study finds disrupted stress response in people with schizophrenia

Researchers develop personalized 'Therapeutic Intervention Fingerprint'

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

Researchers use information from computer tomography images to simulate heart function

LLNL employs high-performance computing for better understanding of TBI

Finnish researchers gain new insights on brain activity during general anesthesia

Johns Hopkins researchers reveal potential of AI in medical imaging and diagnostics

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

Novel theranostic agent designed for precise tumor diagnosis and therapy

MILabs announces innovative PET imaging features in its new VECTor6 system

New molecular imaging method could help effectively tackle brain conditions

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News